On this episode of the podcast, Army Col. Vic Suarez (RET.) and Oxford Pharmaceuticals Chairman Tom Neely expose a quiet but dangerous vulnerability in America’s healthcare system: the offshore manufacturing of generic medications relied upon by U.S. families and service members alike. 

With more than 90% of prescriptions filled by generics sourced largely from China and India, they break down how regulatory loopholes, price manipulation, and weak reimbursement structures have undercut American manufacturers while compromising quality and safety. Drawing on Senate testimony, defense procurement concerns and real-world manufacturing challenges, Suarez and Neely make the case for reshoring active pharmaceutical ingredient production, closing exploitative loopholes, reforming PBMs and distributors, and treating drug manufacturing as the national security priority it has become.